NCT07269626
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Samsung Medical Center Seoul, Select Province/State, South Korea
Clinical trial condition
Oligometastatic Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Oligometastatic Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study